skip to main content

We have been advised that fraudulent emails and faxes regarding unclaimed insurance money have been received by members of the public from a source claiming to be Aird & Berlis LLP. These communications are not from Aird & Berlis LLP. Disregard them and do not engage with the sender in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre.

Students | Join Us | Login |
Back to all Representative Matters
May 10, 2013

A&B Represents Cytochroma Canada Inc. in its Sale to Opko Health, Inc. for Gross Sale Proceeds of up to US$290 Million

On March 4, 2013, a subsidiary of OPKO Health, Inc. (NYSE:OPK), a multi-national biopharmaceutical and diagnostics company, completed the acquisition of all of the assets and undertaking of Cytochroma Canada Inc., a privately held pharmaceutical company with operations in Markham, Ontario and Bannockburn, Illinois. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis. The purchase price paid on closing was approximately US$100 Million and was satisfied by the issuance of OPKO common stock to Cytochroma. There is also an earn-out component for up to an additional US$190 Million, which is payable upon the satisfaction of certain regulatory and revenue milestones.

Cytochroma Canada Inc. was represented in Canada by Aird & Berlis LLP, with a team that included Richard Kimel, Tom Fenton, James Leech and Anne Markle (corporate finance), Barbara Worndl (tax), Aaron Collins (financial services) and Grant Cansfield (intellectual property); and in the United States by Cooley LLP, with a team that included Glen Sato (corporate/securities).

Related Representative Matters

Representative Matters
Pistil Partners Completes Financing and Strategic Acquisition Sherri M. Altshuler, Melanie Cole, Amy Marcen-Gaudaur and Meredith McCann Oct 21, 2019 Pistil Partners Inc. completed a private placement of its common shares and acquisition of Ironside Hemp Company Inc., a private U.S.-based hemp management company.
Representative Matters
Allied Properties REIT Completes $300 Million Debt Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Amy Marcen-Gaudaur, Meredith McCann, Michael D. Smith, Neill Kalvin, Zale Skolnik and Barbara Worndl Oct 09, 2019 Allied Properties Real Estate Investment Trust recently completed a $300 million debt offering of 3.113% series E senior unsecured debentures.
Representative Matters
Thar Process Completes US$10 Million Non-Brokered Private Placement Richard M. Kimel, Adria Leung Lim and Russell J. Sanders Sep 20, 2019 Thar is a U.S.-based provider of CO2 extraction and purification solutions for the hemp and cannabis industries.